Join FDLI at an Author Happy Hour to discuss the Spring 2021 Update magazine article, “Will 2021 Be a Pivotal Year for the CBD Industry? A Look at the Regulatory Landscape and Potential for Change.” Authors Liz Oestreich and Madeleine Giaquinto of Greenleaf Health Inc. will lead a discussion on CBD enforcement trends in 2021, potential legislative action, and creation of a regulatory framework. Along with your peers in the food and drug law community, be prepared to engage in a dialogue on the topics presented in the article, all while enjoying your favorite beverage. This member-only benefit is limited to 20 attendees to encourage active dialogue in a virtual setting.
Authors and Article
Elizabeth (Liz) Oestreich, Vice President, Regulatory Compliance, Greenleaf Health, Inc.
Madeleine Giaquinto, Manager, Regulatory Affairs, Greenleaf Health, Inc.
May 12, 2021
5:00 PM
Registration is open to FDLI members only and is first come, first served. Tickets are limited to 20 participants to facilitate conversation.
This is a complimentary event.
Questions About FDLI Membership?
Contact our membership team at [email protected].
For other questions, please contact Paige Samson.
ELIZABETH (LIZ) OESTREICH is Vice President, Regulatory Compliance at Greenleaf Health Inc. Liz provides strategic regulatory guidance to clients in the cannabis, tobacco, pharmaceutical, and medical device industries with specific focus on FDA compliance.
MADELEINE GIAQUINTO is Manager of Regulatory Affairs at Greenleaf Health, Inc. She provides clients with timely analysis of FDA regulations, policies, and guidance documents and strategic advice on FDA engagement regarding compliance-focused issues and good practice standards for FDA-regulated products.